Squarepoint’s Epizyme, Inc EPZM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-20,509
Closed -$30K 3703
2022
Q2
$30K Buy
+20,509
New +$15.1K ﹤0.01% 2753
2022
Q1
Sell
-100,416
Closed -$251K 3852
2021
Q4
$251K Buy
+100,416
New +$395K ﹤0.01% 2555
2021
Q1
Sell
-36,159
Closed -$393K 3826
2020
Q4
$393K Sell
36,159
-44,212
-55% -$545K ﹤0.01% 2003
2020
Q3
$959K Buy
80,371
+8,314
+12% +$111K 0.01% 1022
2020
Q2
$1.16M Buy
72,057
+57,348
+390% +$1M 0.02% 856
2020
Q1
$228K Buy
+14,709
New +$316K 0.01% 1417
2019
Q2
Sell
-77,700
Closed -$963K 2766
2019
Q1
$963K Buy
77,700
+6,247
+9% +$69.8K 0.01% 1128
2018
Q4
$440K Buy
71,453
+37,753
+112% +$288K 0.01% 1321
2018
Q3
$357K Buy
33,700
+15,151
+82% +$173K ﹤0.01% 1462
2018
Q2
$251K Buy
18,549
+4,497
+32% +$70K ﹤0.01% 1456
2018
Q1
$249K Buy
+14,052
New +$237K ﹤0.01% 1401
2017
Q4
Sell
-25,902
Closed -$493K 2419
2017
Q3
$493K Buy
25,902
+12,479
+93% +$190K 0.01% 986
2017
Q2
$203K Buy
+13,423
New +$203K ﹤0.01% 1302
2016
Q1
Sell
-10,300
Closed -$165K 1529
2015
Q4
$165K Buy
+10,300
New +$153K 0.02% 1053

Other funds holding EPZM